GENEVA, Feb. 2 -- EOS RESEARCH SA (Via Pretorio 136900 Lugano) filed a patent application (PCT/EP2025/070939) for "CHECKPOINT INHIBITORS IN THE TREATMENT OF GLIOBLASTOMA MULTIFORME" on Jul 22, 2025. With publication no. WO/2026/022122, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VESCOVI, Angelo Luigi (Via al Parco 136817 Maroggia Valmara)

Abstract: The present invention concerns the use of specific proteins which are effective in the treatment of cancer by inhibiting the immune escape mechanism in a subject in need t...